Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer.

Macedo, F; Monteiro, J; Pereira, T Cunha; Monteiro, A R; Felix Soares, R; Bonito, N; Sousa, G

Macedo, F; Monteiro, J; Pereira, T Cunha; Monteiro, A R; Felix Soares, R; Bonito, N; Sousa, G.

Afiliação

Macedo F; Medical Oncology Department, Portuguese Oncology Institute of Coimbra, Portugal.
Monteiro J; Medical Oncology Department, Portuguese Oncology Institute of Coimbra, Portugal.
Pereira TC; Medical Oncology Department, Portuguese Oncology Institute of Coimbra, Portugal.
Monteiro AR; Medical Oncology Department, Portuguese Oncology Institute of Coimbra, Portugal.
Felix Soares R; Medical Oncology Department, Portuguese Oncology Institute of Coimbra, Portugal.
Bonito N; Medical Oncology Department, Portuguese Oncology Institute of Coimbra, Portugal.
Sousa G; Medical Oncology Department, Portuguese Oncology Institute of Coimbra, Portugal.

Gastroenterol Hepatol Bed Bench ; 15(1): 93-98, 2022.

Article em En | MEDLINE | ID: mdl-35611253

Palavras-chave

RAS gene; circulating tumor cell; colorectal cancer; molecular targeted therapies; real-time PCR

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gastroenterol Hepatol Bed Bench Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google